Needham & Company maintained a Buy rating on Cepheid (NASDAQ: CPHD), and cut the price target to $47.00 (from $70.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Piper Jaffray Cuts Price Target on Cepheid (CPHD) Following Preliminary 3Q Results October 14, 2015 9:12 AM Leerink Partners Cuts Price Target on Cepheid (CPHD) Following 3Q Pre-Announcement October 14, 2015 8:42 AM Raymond James Downgrades Cepheid (CPHD) to Market PerformOctober 14, 2015 6:53 AM After-Hours Movers 10/13: (SNDK) (MU) (WDC) Higher; (CPHD) (INTC) (JPM) Lower (more...)October 13, 2015 6:01 PM Cepheid (CPHD) Announces Weak Prelim. Q3 Results; Trims FY15 OutlookOctober 13, 2015 4:05 PM Cepheid Reports Preliminary Results For 2015 Third QuarterOctober 13, 2015 4:03 PM